Venture Firm Flagship Bets £100 Million to Build AI-Driven Drug Companies in Britain
The venture firm will back the London effort with an initial £100 million and plans to recruit about 50 scientist-entrepreneurs.
9 Articles
9 Articles
Venture firm Flagship bets £100 million to build AI-driven drug companies in Britain
LONDON, Nov 16 : Flagship Pioneering is opening its first lab for creating companies outside the United States, putting £100 million ($131.94 million) behind a new UK-based effort to fund and build AI-driven biotech companies, the venture firm said on Monday. The move is a first for a firm that has crea
Flagship’s Afeyan Sees UK Bet Creating Next Moderna
Flagship Pioneering founder and CEO Noubar Afeyan says the biotech venture firm hopes its new UK investment can grow to as much as £600 million “relatively soon,” as it establishes its first full-scale company-creation operation outside the US. Speaking on Bloomberg’s “The Pulse With Francine Lacqua”, the Moderna co-founder explains why Flagship chose the UK, how AI could accelerate drug discovery and the creation of new biotech companies, and w…
Flagship launches UK lab to build AI-driven biotechs with £100M investment
Flagship Pioneering, the life science investor behind the likes of Moderna, has launched a new lab in London focused on building “AI-native platform companies” in the UK. The announcement marks Flagship’s first major investment in ...
Moderna creator Flagship Pioneering brings £100M AI lab to London - European Biotechnology Magazine
U.S. biotech venture creator Flagship Pioneering is investing an initial £100 million (€120 million) to establish an AI-focused company-creation lab in London, marking the first expansion of its company-building model outside the United States.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium












